Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Streamex Corp. announced that a leading institutional investment manager has launched a gold-denominated delta-neutral strategy using GLDY, its gold-backed tokenized asset, with an initial investment of $1 million. This marks a significant milestone as Streamex meets its ninety-day objective to convert institutional allocations into GLDY, potential…
Profusa, Inc. announced progress in its quality management certification under ISO 13485 through GMED, moving closer to obtaining MDR conformity assessment and CE marking for its Lumee Oxygen Platform, a biosensor technology for continuous tissue oxygen monitoring. This milestone reflects enhanced compliance with European medical device regulations…
Kala Bio and Virotek have signed a non-binding letter of intent with a U.S. DNA testing platform to resell Virotek's genetic testing products, potentially expanding distribution beyond ophthalmology and creating new commercial channels. The agreement is still subject to finalization of terms and definitive agreements. Kala anticipates this could ge…
Immuneering Corporation announced that data from its ongoing Phase 3 MAPKeeper 301 trial evaluating atebimetinib in combination with chemotherapy for first-line treatment of metastatic pancreatic cancer will be presented at the ESMO Congress 2026. The trial investigates a novel Deep Cyclic Inhibitor designed to improve survival by shrinking tumors,…
Lululemon's share price has been punished after weak sales and a cut to guidance, leaving the stock trading at single-digit earnings multiples and near 52-week lows. The balance sheet and margins still give the company room to recover if product and inventory moves stick. We lay out a buy plan with an entry, stop, and target, plus the catalysts tha…
Palantir is showing bullish technicals, improving fundamentals and fresh government contract relevance that together argue for another upside leg. The stock trades near $191.77 with a strong MACD, rising EMAs and a growing free cash flow base. I layout a tactical long trade with entry, stop and target aligned to these drivers and explicit horizon a…
TurboGen Ltd., a developer of combined heat and power systems based on multifuel microturbines, reported financial results for the first half of 2026, highlighting a $7.2 million cash position as of June 30, supplemented by a recent $5 million private placement. The company commenced Nasdaq trading in August 2026 and is preparing for initial instal…
Microchip Technology announced new 65V digital power monitor families PAC1761 and PAC1861 designed to support growing 48V power architectures across automotive, AI/data center, networking, and industrial sectors. These devices offer enhanced voltage measurement headroom, transient spike protection, and energy-aware real-time power insights to build…
Bank of America (BAC) is an actionable long after a selloff that pushed sentiment to oversold levels. The stock trades at about $56.12 with a P/E around 12-13, a tangible dividend and improving efficiency from AI investments. This trade targets a bounce toward $64 over the next 45 trading days with a disciplined stop at $52.50.
Auddia Inc. (NASDAQ: AUUD) has adjourned its Special Meeting of Stockholders to October 7, 2026, to allow additional time for shareholders to vote on the proposed merger with Thramann Holdings. Currently, approximately 88% of votes cast support the merger, but a majority of all outstanding shares must approve the transaction. Upon completion, the c…
Ethan Allen Interiors Inc. filed its definitive proxy statement ahead of the November 4, 2026 Annual Meeting, urging shareholders to vote for its five highly qualified director nominees in response to a proxy contest instigated by 5.2% shareholder DGB Investment. The company highlights its strong five-year shareholder return of 49.1%, a debt-free b…
Cullinan Therapeutics, a clinical-stage biopharmaceutical company, announced key upcoming clinical data presentations in late 2026 for its T cell engager drug candidates targeting autoimmune diseases and cancer. Highlights include upcoming multi-dose regimen data for Velinotamig in SLE, CLN-978 in SLE, RA, and Sjögren’s disease, and updated Phase 1…
Pasqal Holding SA announced its first half 2026 financial results, highlighting 14% year-over-year revenue growth driven by a 34% increase in QPU-related services. The company advanced its quantum computing platform by scaling to over 1,000 physical qubits and expanding commercial partnerships with major players like NVIDIA, Google, and Saudi Aramc…
X-Energy's subsidiary TRISO-X has completed vertical construction of TX-1, a cutting-edge nuclear fuel fabrication facility in Oak Ridge, Tennessee. This milestone enables progression to interior buildout and equipment installation, aiming to produce advanced TRISO nuclear fuel for multiple Xe-100 small modular reactors. The project benefits from r…
Mesoblast Limited has received FDA approval to implement the T-cell Proliferation Inhibition BioAssay (TIBA) for release and stability monitoring of its FDA-approved mesenchymal stromal cell product, Ryoncil. This new potency assay complements existing tests to ensure consistent potency and clinical effectiveness, supporting the commercial release …
Ligand Pharmaceuticals has entered a financing agreement with AvenCell Therapeutics to provide up to $47 million to support clinical development of AvenCell's allogeneic CAR-T therapies targeting acute myeloid leukemia and B-cell malignancies. Ligand will receive royalties on the sales of AvenCell's pipeline assets, with funding released upon achie…
Vistagen announced positive exploratory findings from two clinical trials indicating that its lead product candidate, fasedienol nasal spray, shows potential efficacy in treating individuals with very severe social anxiety disorder. These findings include statistically significant improvements in anxiety symptoms during public speaking challenges a…
Tri Pointe Homes has acquired 60.4 acres in Bluffton, South Carolina to develop 76 single-family home sites as the final phase of the New Riverside mixed-use community. This strategic acquisition taps into one of the fastest-growing residential markets in the Southeast, with construction targeted to start in late 2027 and sales in 2028. The develop…
Satellos Bioscience Inc. announced FDA clearance of its IND application to begin a Phase 2 clinical trial for forazapadin, a novel oral small molecule drug candidate aimed at muscle regeneration, targeting facioscapulohumeral muscular dystrophy (FSHD). The company secured up to $5 million in non-dilutive financing from the FSHD Canada Foundation to…
The Lovesac Company announced its participation in the 2026 Global Consumer & Retail Conference hosted by Telsey Advisory Group. The company will hold a fireside chat on October 8, 2026, which will be webcast live and available on the company's investor relations website. Lovesac is known for its modular furniture products focusing on innovation an…
Advanced Micro Devices (AMD) is uniquely positioned to benefit as AI adoption shifts from monolithic models to memory-hungry agents and context-rich workloads. With data-center revenue doubling year-over-year and a market cap north of $1 trillion, AMD trades at a premium but has measurable product and demand catalysts that justify a tactical long i…
Descartes Systems Group launched the Descartes Datamyne AI Agent, a cutting-edge conversational AI integrated into its global trade intelligence platform. The AI Agent leverages over 500 million annual shipment records from 230 markets to help logistics, sourcing, sales, and supply chain teams reduce trade data research and analysis time by up to 9…
Amesite Inc. announced a new customer win under its NurseMagic® minimum enterprise pricing model, set at $1,099/month for organizations with up to 1,000 patient census. This pricing strategy aims to serve smaller post-acute care providers with attractive margins while scaling revenue with larger deployments. The company highlighted strong gross mar…
Ducommun Incorporated held its first Investor Day in four years, reporting strong progress against its VISION 2027 strategic plan and unveiling the VISION 2032 roadmap. The company aims to accelerate growth through expanded acquisitions, defense franchise expansion, commercial aerospace recovery, and investment in proprietary engineered products. I…
Bunge Global (BG) trades below recent short-term averages while still offering a mid-cycle EPS story, buyback authorization and a meaningful dividend yield. We see a mispricing driven by integration concerns and near-term cash conversion noise. Our tactical long targets $135 over the next 180 trading days with a hard stop at $100 to manage downside…
